Skip to main content
BEAT
NASDAQ Industrial Applications And Services

HeartBeam Seeks Shareholder Approval for 6% Equity Plan Dilution Amidst Cash Conservation

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$0.839
Mkt Cap
$46.565M
52W Low
$0.54
52W High
$4
52W Position info
55% above low
Off High info
79% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

BEAT sits 55% above its 52-week low of $0.54.

Summary

HeartBeam is proposing a 6% increase in its equity incentive plan, signaling future dilution for compensation and highlighting the company's continued focus on cash conservation following recent capital raises and a "going concern" warning.


Key Events · Corporate Governance and Compliance · BEAT

  • Significant Equity Plan Expansion Proposed

    Shareholders will vote on increasing the 2022 Equity Incentive Plan by 3,000,000 shares, which the company states would result in an additional 6% potential dilution if approved.

  • Executive Compensation Paid in Equity

    The company has been paying a portion of executive and director compensation with equity instead of cash, reflecting ongoing cash conservation efforts.

  • Annual Meeting Agenda Set

    Other proposals for the July 31, 2026, Annual Meeting include the re-election of nine directors and the ratification of CBIZ CPAs P.C. as the independent auditor for 2026.

  • Compliance Lapses Noted

    The filing discloses multiple late Form 4 filings by directors and officers in 2025, indicating past compliance oversights.


Analysis · BEAT · Industrial Applications And Services

HeartBeam is asking shareholders to approve a significant increase in its equity incentive plan, which would allow for an additional 6% potential dilution. This move, coupled with the company's recent practice of paying executive and director compensation with equity instead of cash, underscores ongoing efforts to conserve cash in light of its "going concern" status. While necessary for attracting and retaining talent, this level of potential dilution is a notable concern for existing shareholders.

How filings like this one have moved

In the 30 days to Oct 2, 2026, 29.4% of the 1637 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.57%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, BEAT was trading at $0.84 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $46.6M. The 52-week trading range was $0.54 to $4.00. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BEAT - Latest Insights

BEAT
Sep 28, 2026, 7:00 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $0.370
Real-time Price: $0.4225 info
Change: +$0.0525 (+14%) info
Market Cap: $23.808M info
BEAT
Aug 14, 2026, 5:34 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $0.507
Real-time Price: $0.4225 info
Change: -$0.0845 (-17%) info
Market Cap: $23.808M info
BEAT
Aug 14, 2026, 5:01 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.507
Real-time Price: $0.4225 info
Change: -$0.0845 (-17%) info
Market Cap: $23.808M info
BEAT
Aug 13, 2026, 4:30 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $0.595
Real-time Price: $0.4225 info
Change: -$0.1725 (-29%) info
Market Cap: $23.808M info
BEAT
Aug 13, 2026, 4:02 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.5972
Real-time Price: $0.4225 info
Change: -$0.1747 (-29%) info
Market Cap: $23.808M info